Cosimo Gianluca Fortuna

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Fluorescence Imaging

Single Molecule

Circulating Tumor

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Maria Sipala, Gianfranco Cavallaro, Giuseppe Forte, Cristina Satriano, Alessandro Giuffrida, Aurore Fraix, Angelo Spadaro, Salvatore Petralia, Carmela Bonaccorso, Cosimo Gianluca Fortuna, Simone Ronsisvalle
Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2. Molecules (Basel, Switzerland) 28 (9) (2023)
Alessio Cesaretti, Eleonora Calzoni, Nicolò Montegiove, Tommaso Bianconi, Martina Alebardi, Maria Antonietta La Serra, Giuseppe Consiglio, Cosimo Gianluca Fortuna, Fausto Elisei, Anna Spalletti
Lighting-Up the Far-Red Fluorescence of RNA-Selective Dyes by Switching from Ortho to Para Position. International journal of molecular sciences 24 (5) (2023)
Alessio Cesaretti, Eleonora Calzoni, Nicolò Montegiove, Tommaso Bianconi, Martina Alebardi, Maria Antonietta La Serra, Giuseppe Consiglio, Cosimo Gianluca Fortuna, Fausto Elisei, Anna Spalletti
Lighting-Up the Far-Red Fluorescence of RNA-Selective Dyes by Switching from Ortho to Para Position. International journal of molecular sciences 24 (5) (2023)
Alessio Cesaretti, Eleonora Calzoni, Nicolò Montegiove, Tommaso Bianconi, Martina Alebardi, Maria Antonietta La Serra, Giuseppe Consiglio, Cosimo Gianluca Fortuna, Fausto Elisei, Anna Spalletti
Lighting-Up the Far-Red Fluorescence of RNA-Selective Dyes by Switching from Ortho to Para Position. International journal of molecular sciences 24 (5) (2023)
Federica Maria Sipala, Gianfranco Cavallaro, Giuseppe Forte, Cristina Satriano, Alessandro Giuffrida, Aurore Fraix, Angelo Spadaro, Salvatore Petralia, Carmela Bonaccorso, Cosimo Gianluca Fortuna, Simone Ronsisvalle
Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2. Molecules (Basel, Switzerland) 28 (9) (2023)